Correlation Between Machine Learning-based Characterization of HER2 Protein Expression by Immunohistochemistry and Response to Neoadjuvant Treatment in HER2+Breast Cancer

被引：0
|
作者：
Kurt, Busem Binboga [1 ]
Kirkup, Christian [2 ]
Ogayo, Esther Ritah [1 ]
Krause, Emma [2 ]
Cramer, Harry [1 ]
Degryse, Sandrine [2 ]
Hennek, Stephanie [2 ]
Rahman, Tasnim [1 ]
Tarantino, Paolo [1 ]
Chambre, Laura [2 ]
Trotter, Ben [2 ]
Hipp, Jennifer [2 ]
Drage, Michael [2 ]
Tolaney, Sara [1 ]
Schnitt, Stuart [3 ]
Waks, Adrienne [1 ]
Mittendorf, Elizabeth [4 ]
机构：
[1] Dana Farber Canc Inst, Boston, MA USA
[2] PathAI, Boston, MA USA
[3] Harvard Med Sch, Dana Farber Canc Inst, Brigham & Womens Hosp, Boston, MA USA
[4] Dana Farber Canc Inst, Brigham & Womens Canc Ctr, Boston, MA USA
来源：
LABORATORY INVESTIGATION | 2024年 / 104卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
102
引用
收藏
页码：S121 / S123
页数：3
相关论文
共 50 条
  • [41] Dual HER2 blockage with lapatinib and trastuzumab for Japanese patients with HER2+breast cancer
    Iwata, H.
    Yamamoto, N.
    Masuda, N.
    Bando, H.
    Kuroi, K.
    Ohno, S.
    Kasai, H.
    Morita, S.
    Sakurai, T.
    Toi, M.
    BREAST, 2015, 24 : S95 - S95
  • [42] Treatment of HER2+breast cancer: a retrospective of disease prognosis with loss of HER2 amplification on residual disease after neoadjuvant treatment in a community hospital setting
    Uczkowski, Dariusz
    Sekhri, Arunabh
    Gupta, Shilpi
    Gendler, Leah
    Misiukiewicz, Krzysztof
    Levin, Miles
    Guerin, Bonni
    AMERICAN JOURNAL OF CANCER RESEARCH, 2023, 13 (06): : 2564 - 2571
  • [43] Methodology Used to Determine HER2 Status Correlates with Response to Neoadjuvant Chemotherapy in HER2 Positive Breast Cancer
    Cheng, Esther
    McIntire, Patrick
    D'Alfonso, Timothy
    Ginter, Paula
    MODERN PATHOLOGY, 2018, 31 : 54 - 54
  • [44] Methodology Used to Determine HER2 Status Correlates with Response to Neoadjuvant Chemotherapy in HER2 Positive Breast Cancer
    Cheng, Esther
    McIntire, Patrick
    D'Alfonso, Timothy
    Ginter, Paula
    LABORATORY INVESTIGATION, 2018, 98 : 54 - 54
  • [45] Changes in HER2 status after neoadjuvant treatment of breast cancer
    Skalova, H.
    Dundr, P.
    Povysil, C.
    Pribylova, O.
    Petruzelka, L. B.
    Tvrdik, D.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [46] Correlation of HER2 gene amplification, HER2 and EGFR expression (protein and mRNA) with lapatinib efficacy in women with metastatic breast cancer
    Press, M. F.
    Finn, R. S.
    Di Leo, A.
    Cameron, D. A.
    Geyer, C. E.
    Martin, A.
    Newstat, B.
    Gagnon, R.
    Arbushites, M.
    Koehler, M.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [47] Loss of HER2 expression in HER2-positive breast cancer patients after neoadjuvant therapy
    Sang, Yuting
    Wu, Jiong
    Yang, Benlong
    CANCER RESEARCH, 2022, 82 (04)
  • [48] Stability of HER2 Expression in Residual Breast Cancer Following Neoadjuvant Anti-HER2 Therapy
    Mir, Mariam O.
    Sahoo, Sunati
    Fang, Yisheng
    Peng, Yan
    Hwang, Helena
    Czapla, Agata
    Koduru, Prasad
    Sarode, Venetia
    LABORATORY INVESTIGATION, 2018, 98 : 91 - 91
  • [49] HER2-low status and response to neoadjuvant chemotherapy in HER2 negative early breast cancer
    Luciana de Moura Leite
    Marcelle Goldner Cesca
    Monique Celeste Tavares
    Debora Maciel Santana
    Erick Figueiredo Saldanha
    Paula Tavares Guimarães
    Daniella Dias Silva Sá
    Maria Fernanda Evangelista Simões
    Rafael Lima Viana
    Francisca Giselle Rocha
    Simone Klog Loose
    Sinara Figueiredo Silva
    Rafaela Pirolli
    Camilla Albina Zanco Fogassa
    Bruna Raphaeli Silva Mattos
    Fernando Augusto Batista Campos
    Solange Moraes Sanches
    Vladmir Cláudio Cordeiro de Lima
    Noam Falbel Pondé
    Breast Cancer Research and Treatment, 2021, 190 : 155 - 163
  • [50] HER2-low status and response to neoadjuvant chemotherapy in HER2 negative early breast cancer
    de Moura Leite, Luciana
    Cesca, Marcelle Goldner
    Tavares, Monique Celeste
    Santana, Debora Maciel
    Saldanha, Erick Figueiredo
    Guimaraes, Paula Tavares
    Sa, Daniella Dias Silva
    Simoes, Maria Fernanda Evangelista
    Viana, Rafael Lima
    Rocha, Francisca Giselle
    Loose, Simone Klog
    Silva, Sinara Figueiredo
    Pirolli, Rafaela
    Fogassa, Camilla Albina Zanco
    Mattos, Bruna Raphaeli Silva
    Campos, Fernando Augusto Batista
    Sanches, Solange Moraes
    de Lima, Vladmir Claudio Cordeiro
    Ponde, Noam Falbel
    BREAST CANCER RESEARCH AND TREATMENT, 2021, 190 (01) : 155 - 163
12345